|
Market Closed -
NYSE
04:00:02 2026-10-16 pm EDT
|
5-day change | 1st Jan Change | ||
| 254.06 USD | +0.14% |
|
+6.94% | +23.63% |
| Oct. 16 | UBS Adjusts Cardinal Health Price Target to $295 From $280, Maintains Buy Rating | MT |
| Oct. 13 | Cardinal Health Could Benefit From RayzeBio's Phase 3 Success, RBC Says | MT |
| Market Cap | 58.83B 52.29B 48.47B 44.1B 83.22B 5,583B 84.55B 583B 228B 2,914B 221B 216B 9,288B | P/E 2027 * |
24.8x | P/E 2028 * | 22x |
|---|---|---|---|---|---|
| Enterprise Value | 60.7B 53.96B 50.01B 45.5B 85.87B 5,761B 87.24B 601B 236B 3,006B 228B 223B 9,584B | EV / Sales 2027 * |
0.23x | EV / Sales 2028 * | 0.21x |
| Free-Float |
85.66% | Yield 2027 * |
0.83% | Yield 2028 * | 0.84% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CAH | Delayed | |
CBOE
| CAH | Real-time | |
|
London S.E.
| 0HTG | Delayed | |
|
Tradegate
| CLH | Real-time | |
|
Mexican S.E.
| CAH * | End-of-day quote | |
|
Boerse Muenchen
| CLH | Real-time | |
|
Deutsche Boerse AG
| CLH | Delayed | |
|
Xetra
| CLH | Delayed | |
|
Börse Stuttgart
| CLH | Delayed | |
|
Berne S.E.
| CLH | End-of-day quote | |
|
Borsa Italiana
| 1CAH | End-of-day quote | |
|
Wiener Boerse
| CAHE | End-of-day quote |
Last Transcript: Cardinal Health, Inc.
| 1 day | +0.14% | ||
| 1 week | +6.94% | ||
| Current month | +14.18% | ||
| 1 month | +12.73% | ||
| 3 months | +11.18% | ||
| 6 months | +18.73% | ||
| Current year | +23.63% |
| 1 week | 236.19 |  | 255.56 |
| 1 month | 216.7 | | 255.56 |
| Current year | 180.45 | | 258.3 |
| 1 year | 155.84 | | 258.3 |
| 3 years | 90.19 | | 258.3 |
| 5 years | 45.85 | | 258.3 |
| 10 years | 39.05 | | 258.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jason Hollar
CEO | Chief Executive Officer | 53 | 2022-08-31 |
Aaron Alt
DFI | Director of Finance/CFO | 55 | 2023-02-09 |
Ben Brinker
COO | Chief Operating Officer | - | 2022-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2026-03-19 | |
Nancy Killefer
BRD | Director/Board Member | 71 | 2015-09-13 |
Akhil Johri
BRD | Director/Board Member | 64 | 2018-02-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/19/26 | Sell | Chief Executive Officer | -44,529 | 0.0190% | ||
| 8/19/26 | Sell | Controller/Auditor | -2,302 | 0.0010% | ||
| 8/18/26 | Sell | Executive/Senior Manager | -7,354 | 0.0031% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.14% | +6.94% | +62.43% | +170.85% | 58.83B | |
| +0.43% | +6.59% | +56.57% | +107.01% | 1,120B | |
| +0.90% | -2.25% | +32.26% | +67.33% | 616B | |
| +0.71% | +3.24% | +24.33% | +91.20% | 504B | |
| -0.12% | +5.28% | +34.83% | +58.94% | 367B | |
| +0.52% | +0.24% | +72.13% | +43.10% | 360B | |
| -0.16% | +3.85% | +19.63% | +47.00% | 288B | |
| -0.82% | +2.66% | -1.74% | +17.72% | 258B | |
| -0.35% | +4.25% | +44.74% | +52.51% | 234B | |
| -0.75% | +3.32% | +27.18% | +96.05% | 194B | |
| Average | -0.31% | +3.67% | +37.24% | +75.17% | 399.97B | |
| Weighted average by Cap. | -0.39% | +3.57% | +39.73% | +75.89% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 266B 236B 219B 199B 376B 25,223B 382B 2,632B 1,032B 13,163B 997B 976B 41,960B | 282B 251B 232B 211B 399B 26,750B 405B 2,791B 1,094B 13,959B 1,058B 1,035B 44,500B |
| Net income | 2.32B 2.07B 1.91B 1.74B 3.29B 221B 3.34B 23.01B 9.02B 115B 8.72B 8.53B 367B | 2.61B 2.32B 2.15B 1.96B 3.69B 248B 3.75B 25.85B 10.14B 129B 9.8B 9.59B 412B |
| Net Debt | 1.87B 1.67B 1.54B 1.41B 2.65B 178B 2.69B 18.57B 7.28B 92.85B 7.04B 6.89B 296B | 370M 329M 305M 277M 523M 35.11B 532M 3.66B 1.44B 18.32B 1.39B 1.36B 58.41B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-16 | $254.06 | +0.14% | 1,336,562 |
| 26-10-15 | $253.71 | +2.41% | 2,055,478 |
| 26-10-14 | $247.74 | +3.35% | 1,972,928 |
| 26-10-13 | $239.72 | +0.69% | 1,352,295 |
| 26-10-12 | $238.08 | +0.21% | 1,234,656 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CAH Stock
Select your edition
All financial news and data tailored to specific country editions
